STarting incrEmental Prescription of Peritoneal Dialysis

Recruiting now · Not applicable

Conditions studied: Peritoneal Dialysis (PD), Kidney Failure

In brief

Kidney failure is fatal without dialysis. Peritoneal dialysis (PD) completed at home offers greater flexibility and autonomy for patients . However, PD is often prescribed for 24 hours/day, 7 days/week for every patient starting dialysis. This practice is not evidence-informed, may be unnecessary and potentially harmful. The STEP-PD trial aims to determine the optimal approach to commencing patients on PD through starting at low dose PD and incrementing over time.

Key facts

Study ID: NCT06642597
Run by: The University of Queensland
People needed: 224
Starts: 2025-09-19
Expected to finish: 2029-09-30
Last updated by the study team: 2026-06-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

adults (≥18 years) commencing PD as their first dialysis therapy (and been on dialysis for <1 month)
able to give informed consent

You may not qualify if…

urine output <0.5L/day
previous kidney transplant
unlikely to be on dialysis for ≥1 year.
known or planned pregnancy during the trial

Where it is running

King Chulalongkorn Memorial Hospital — Bangkok, Pathum Wan, Thailand (enrolling)
Blacktown — Blacktown, New South Wales, Australia (enrolling)
Eastern Health — Box Hill, Victoria, Australia (enrolling)
Waitemata — Auckland, New Zealand (enrolling)
Hallym University Sacred Heart Hospital — Chuncheon, Gangwon-do, South Korea (enrolling)
Kyungpook National University — Daegu, South Korea (enrolling)
Taichung Veterans General Hospital — Taichung, Xitun District, Taiwan (enrolling)
Banphaeo General Hospital — Ban Phaeo, Changwat Samut Sakhon, Thailand (enrolling)
Princess Alexandra Hospital — Brisbane, Queensland, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.